You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-17. Route of administration by primary drug of clients entering treatment, 2010 or most recent year available

Part (x) All cannabis outpatient clients by country and usual route of administration (%)

Country		Inject	Smoke/inhale	Eat/drink	Sniff	Others	Route known (n)	Route unknown
Belgium	1	0.1	98.7	0.8	0.4	0.0	2386	155
Bulgaria		0.0	100.0	0.0	0.0	0.0	4	0
Czech Republic		0.0	98.1	0.6	0.8	0.6	361	0
Denmark		0.0	99.0	1.0	0.0	0.0	2147	95
Germany		0.2	98.0	1.2	0.3	0.3	31652	0
Estonia	2	:	100.0	:	:	:	3	0
Ireland		0.0	99.1	0.9	0.0	0.0	1162	2
Greece		0.4	98.9	0.6	0.2	0.0	526	5
Spain	3	0.0	96.6	2.4	0.7	0.3	9263	240
France		0.0	99.4	0.6	0.0	0.0	14486	1385
Italy	4	0.2	98.3	1.1	0.4	0.1	7539	459
Cyprus		0.0	100.0	0.0	0.0	0.0	287	0
Latvia	5	0.0	98.5	1.0	0.5	0.0	195	3
Lithuania		:	:	:	:	:	:	:
Luxembourg		:	25.0	:	25.0	50.0	4	0
Hungary		0.2	95.7	3.4	0.4	0.4	2644	28
Malta	6	0.9	98.1	0.9	:	:	106	0
Netherlands	7	0.0	99.5	0.3	0.1	0.0	3704	1478
Austria		0.1	97.8	1.0	0.9	0.1	783	25
Poland	8	:	100.0	:	:	:	332	1
Portugal	9	0.0	97.7	2.3	0.0	0.0	343	160
Romania		0.0	99.0	1.0	0.0	0.0	100	1
Slovenia		0.0	97.6	2.4	0.0	0.0	41	2
Slovakia		0.0	98.0	0.0	2.0	0.0	152	0
Finland		0.6	99.4	0.0	0.0	0.0	179	0
Sweden		0.0	95.9	3.8	0.3	0.0	1025	16
United Kingdom	10	0.0	96.4	2.7	0.6	0.3	22651	1209
Croatia		:	100.0	:	:	:	795	2
Turkey		:	:	:	:	:	:	:
Norway	11	0.0	100.0	0.0	0.0	0.0	43	1
Total		0.1	97.8	1.6	0.4	0.2	102913	5267

Notes:

: Indicates no data are available.

Percentages are of clients whose route of administration is known (n)

1 - In Belgium if the exact primary drug is not known, the generic category is recorded. In 2010 there were198 Opiates, 7 Cocaine, 7 Stimulants, 2 Hypnotics and Sedatives and 1 Hallucinogens clients with the primary exact drug unknown. Of which 24 and 5 were new clients for respectively Opiates and Stimulants.

2 - Data are from outpatient, inpatient treatment centres and prisons (aggregated data).

3 - Data are from 2009. Data are from Outpatient treatment centres and some treatment units in prison (aggregated data).

4 - In 2010 around 29% of all clients and 30% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

5 - In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

6 - Data refers to outpatient and inpatient treatment centres, low-threshold services and prisons (aggregated data).

7 - Data are from outpatient, inpatient treatment centres and Low-threshold services (aggregated data).

8 - Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

9 - In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria.

10 - Data are from 1st of April 2009 to 31st March 2010.

11 - In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — TDI — outpatient treatment centres.

Download spreadsheet version (.xls)